Navigation Links
Carna Biosciences Signs Distribution Agreement with Shanghai Universal Biotech Company
Date:10/27/2008

KOBE, Japan, Oct. 27 /PRNewswire/ -- Carna Biosciences, Inc. ("Carna") announced on October 27, 2008, the signing of a Distribution Agreement with Shanghai Universal Biotech Company ("SUBC"). Under the terms of this Agreement, SUBC will become the exclusive distributor of Carna's Protein Kinases within China.

With China's emergence as a strong market opportunity, particularly in the life sciences, major biopharmaceutical companies have now established research and production facilities in Shanghai and other regions of China. These facilities seek and require goods to support their internal drug discovery programs. Carna is an established global provider of protein kinases used in the discovery and development of the important class of drugs known as kinase inhibitors. The Agreement with SUBC makes these products readily available to Chinese researchers via SUBC's strong distribution channels.

In addition to major biopharmaceutical presence, tax incentives provided by the Chinese government have provided a fertile environment for the establishment of bio-venture companies and CRO. The Agreement between Carna and SUBC, with its offices in the major cities of Shanghai and Beijing, is anticipated to lead to significantly increased sales opportunities for Carna and further establish its reputation as a global provider of protein kinases.

About Carna

Carna Biosciences, Inc. (http://www.carnabio.com/english/), founded in April 2003, is a Japanese biotechnology company conducting intercellular signaling-based drug discovery programs, and providing drug discovery services to pharmaceutical companies using proprietary technologies in gene cloning, active kinase protein expression, protein purification and homogeneous assay development. The products and services provided by Carna include kinase proteins, assay development services, kinase profiling and screening services, and crystallography products and services.

About SUBC

Shanghai Universal Biotech Company(http://www.univ-bio.com), founded in December 2004, is a Chinese distributor of biological reagents and experimental installations. The company provides antibody and reagent products as an agent of biological companies at home and abroad.
Contact:

Tomohisa Yamazaki, Manager

Corporate Planning

Carna Biosciences, Inc.

Phone: +81-78-302-7039

Fax: +81-78-302-6665

E-mail: ir-team@carnabio.com

URL: http://www.carnabio.com/english/


'/>"/>
SOURCE Carna Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
2. Isis Ibis Biosciences Subsidiary Highlights the Power of the Ibis T5000 Pathogen Identification and Characterization System at the ICAAC/IDSA Meeting
3. LI-COR Biosciences and Euthanex Corporation Provide Anesthesia System for Small Animal Imaging
4. Neurocrine Biosciences Announces Conference Call and Webcast to Present Third Quarter 2008 Financial Results
5. Sangamo BioSciences Announces Third Quarter Conference Call and Webcast
6. Pressure BioSciences, Inc. Provides Corporate Update
7. Isis Announces Award of Up to $8.4 Million in New Government Grants and Contracts to Its Ibis Biosciences Subsidiary for Pathogen Detection and Human Forensics
8. Dr. Charles Sanders to Become Lead Director of Epiphany Biosciences
9. Lumiphore Partners with Biophor Diagnostics, Inc. to Develop Tests for Drugs of Abuse; Appoints Ibis Biosciences Founder David J. Ecker to Board
10. Sangamo BioSciences to Present at Two Upcoming Investor Conferences
11. LI-COR Biosciences Offers $1.75 Million in Matching Funds for Undergraduate Genomics Education
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)...  Biotheranostics today announced that new data will ... Cancer Index (BCI) in identifying which patients with ... for disease recurrence and might benefit from extended ... advancing the understanding of the value of BCI ... inform decisions related to patient treatment. These data ...
(Date:12/8/2016)... Portland, Oregon (PRWEB) , ... December 08, 2016 ... ... modules and the FrontPanel SDK that provide essential device-to-computer interconnect using USB or ... do not require FrontPanel support. The FOMD-ACV-A4 is a small, thin, SODIMM-style module ...
(Date:12/8/2016)... ... 08, 2016 , ... KBioBox llc announced today the launch ... developed a sophisticated “3 click” gene dditing off target analysis program and a ... https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. Scientists, pharmaceutical ...
(Date:12/8/2016)... N.J. , Dec. 8, 2016  Soligenix, ... late-stage biopharmaceutical company focused on developing and commercializing ... an unmet medical need, announced today the long-term ... with SGX942 (dusquetide), a first-in-class Innate Defense Regulator ... in head and neck cancer patients undergoing chemoradiation ...
Breaking Biology Technology:
(Date:11/19/2016)... , Nov. 18, 2016 Securus Technologies, ... solutions for public safety, investigation, corrections and monitoring, announced ... smaller competitor, ICSolutions, to have an independent technology judge ... the most modern high tech/sophisticated telephone calling platform, and ... customers that they do most of what we do ...
(Date:11/15/2016)... , Nov 15, 2016 Research and Markets ... Forecast to 2021" report to their offering. ... ... 16.18 Billion by 2021 from USD 6.21 Billion in 2016, growing ... Growth of the bioinformatics market is driven by the growing ...
(Date:6/22/2016)... ANGELES , June 22, 2016 /PRNewswire/ ... identity management and verification solutions, has partnered ... edge software solutions for Visitor Management, Self-Service ... provides products that add functional enhancements ... partnership provides corporations and venues with an ...
Breaking Biology News(10 mins):